课题基金 / 基金详情

Enhanced Control of Hypertension and Thrombolysis in Stroke Study (STAY ENCHANTED)

Enhanced Control of Hypertension and Thrombolysis in Stroke Study (STAY ENCHANTED)
在中风研究中加强高血压和溶栓控制(STAY ENCHANTED)
批准号:
nhmrc : GNT1101113
负责人:
Dr Shoichiro Sato
金额:
$243.74万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 --

项目摘要

项目成果

Dr Shoichiro Sato的其他基金

相似基金

相关文献

中文摘要
翻译
“凝块破坏”治疗是唯一被批准用于最常见类型的中风,缺血性中风的药物治疗。然而,治疗的吸收仍然很差,主要是由于已知的脑出血的主要风险。STAY ENCHANTED是一项国际临床试验,旨在研究使用较低剂量和/或立即降低血压是否可以使“血栓破裂”更安全。一个更安全、更有效的制度可以对全球健康产生重大影响。
英文摘要
'Clot busting' treatment is the only approved medical treatment for the commonest type of stroke, ischaemic stroke. However, uptake of treatment remains poor, mainly due to the known major risk of bleeding in the brain. STAY ENCHANTED is an international clinical trial to investigate whether 'clot-busting' can be made safer using a lower dose and/or immediate blood pressure lowering. A safer more effective regime could have a major global health impact.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)
  • 批准号:
    nhmrc : GNT1103886
  • 项目类别:
    Project Grants
  • 资助金额:
    $525.63万
  • 财政年份:
    2016
  • 负责人:
    Dr Shoichiro Sato
  • 依托单位:
国内基金
海外基金
Cortical control of internal state in the insular cortex-claustrum region